Neoantigen Vaccine With Pembrolizumab Has Clear Benefit in Melanoma Neoantigen Vaccine With Pembrolizumab Has Clear Benefit in Melanoma

Jeffrey S. Weber, MD, PhD, discusses recently released data on a new antigen vaccine with pembrolizumab.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news